Evidence map›Paper›PMID 39034993›Full record

ArticleFrontiers in immunology2024

Suppression of interferon α and γ response by Huwe1-mediated Miz1 degradation promotes SARS-CoV-2 replication.

Vinothini Arunagiri, Laura Cooper, Huali Dong, Jake Class, Indrani Biswas, Sujan Vahora, Riddhi Deshpande, Khushi H Gopani, Guochang Hu, Justin M Richner and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. TRIM21 is a molecular rheostat for influenza A virus replication.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Vinothini Arunagiri *Department of Surgery, College of Medicine, Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.
Laura Cooper *Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Huali DongDepartment of Surgery, College of Medicine, Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.
Jake ClassDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Indrani BiswasDepartment of Surgery, College of Medicine, Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.
Sujan VahoraDepartment of Surgery, College of Medicine, Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.
Riddhi DeshpandeDepartment of Surgery, College of Medicine, Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.
Khushi H GopaniDepartment of Surgery, College of Medicine, Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.
Guochang HuDepartments of Anesthesiology and Pharmacology & Regenerative Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Justin M RichnerDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Lijun RongDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Jing LiuDepartment of Surgery, College of Medicine, Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.

Funding

Role Of p120 Catenin In Sepsis-Induced Lung InjuryR01HL104092 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HU, GUOCHANG · 2010 to 2020
$3.9M
The transcription factor Miz1-mediated mechanisms of lung agingR01HL141459 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIU, JING · 2018 to 2021
$2.0M
ER-phagy regulation of immune response: mechanisms and significanceR01HL173334 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Guochang Hu · 2024 to 2026
$1.8M
Targeting the host immune response during sepsisR01HL152696 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HU, GUOCHANG · 2020 to 2023
$1.8M
NHLBI NIH HHS R01 HL104092NHLBI NIH HHS R01 HL141459NHLBI NIH HHS R01 HL152696NHLBI NIH HHS R01 HL173334
6 · The paper itself

Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been demonstrated to limit the host interferon response; however, the underlying mechanism remains unclear. Here, we found that SARS-CoV-2 infection upregulated the E3 ubiquitin ligase Huwe1, which in turn facilitated the degradation of the transcription factor Miz1. The degradation of Miz1 hampered interferon alpha and gamma responses, consequently fostering viral replication and impeding viral clearance. Conversely, silencing or inhibiting Huwe1 enhanced the interferon responses, effectively curbing viral replication. Consistently, overexpressing Miz1 augmented the interferon responses and limited viral replication, whereas silencing Miz1 had the opposite effect. Targeting Huwe1 or overexpressing Miz1 elicited transcriptomic alterations characterized by enriched functions associated with bolstered antiviral response and diminished virus replication. Further study revealed Miz1 exerted epigenetic control over the transcription of specific interferon signaling molecules, which acted as common upstream regulators responsible for the observed transcriptomic changes following Huwe1 or Miz1 targeting. These findings underscore the critical role of the Huwe1-Miz1 axis in governing the host antiviral response, with its dysregulation contributing to the impaired interferon response observed during COVID-19.

Indexed as

COVID-19Interferon-alphaInterferon-gammaSARS-CoV-2Tumor Suppressor ProteinsUbiquitin-Protein LigasesVirus ReplicationAnimalsChlorocebus aethiopsHEK293 CellsHumansKruppel-Like Transcription FactorsProtein Inhibitors of Activated STATProteolysisHUWE1 protein, humanInterferon-alphaInterferon-gammaKruppel-Like Transcription FactorsProtein Inhibitors of Activated STATTumor Suppressor ProteinsUbiquitin-Protein LigasesZBTB17 protein, humanHUWE1interferon alpha and gamma responsesMiz1SARS-CoV-2transcriptional regulation

Identifiers

PMID39034993
PMCPMC11257858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.